Table 2.
Sociodemographic variables | Insomnia symptoms (n = 320) | No insomnia symptoms (n = 161) | p |
---|---|---|---|
Age (years) | 44.4 ± 11.8 | 40.2 ± 9.3 | 0.04* |
Gender (female) | 34.7 | 13.7 | 0.0001*, ** |
Nationality (foreign) | 9.1 | 11.2 | 0.46 |
Education (primary education) | 32.5 | 34.8 | 0.62 |
Employed (working) | 88.3 | 86.6 | 0.52 |
Marital status (married) | 30.3 | 38.5 | 0.07 |
Living with someone | 30.6 | 31 | 0.21 |
Criminal record (prison) | 24.9 | 23.4 | 0.78 |
Clinical variables related to comorbidities | |||
Medical history | 64.7 | 52.8 | 0.01* |
Psychiatric history | 68.1 | 60.3 | 0.10 |
Axis I | 49.4 | 42.3 | 0.18 |
Anxiety disorder | 19.4 | 8.1 | 0.001* |
Psychiatric history | 68.1 | 60.3 | 0.10 |
Axis I | 49.4 | 42.3 | 0.18 |
Anxiety disorder | 19.4 | 8.1 | 0.001*, ** |
Depressive disorder | 19.6 | 16.6 | 0.32 |
Attention deficit hyperactivity disorder | 15.3 | 8.7 | 0.04* |
Psychotic disorder | 8.4 | 8.7 | 0.92 |
Bipolar disorder | 3.8 | 1.9 | 0.26 |
Axis II | 51.6 | 43.1 | 0.09 |
Cluster B | 33.1 | 19.9 | 0.002*, ** |
Other personality disorder | 11.6 | 10.1 | 0.81 |
Cluster C | 5 | 4.3 | 0.75 |
Cluster A | 1.9 | 1.9 | 0.99 |
Prior psychiatric admissions | 26.8 | 20 | 0.09 |
Clinical variables related to consumption | |||
Age at start of consumption | 17.9 ± 6.4 | 17.5 ± 6.4 | 0.44 |
Age of onset of substance use disorder | 24.3 ± 8.04 | 23.8 ± 8.6 | 0.55 |
Years of addiction | 19.6 ± 10.2 | 18.6 ± 13.0 | 0.87 |
Main Substance Use Disorder | % | % | |
Alcohol | 57.8 | 51.6 | 0.40 |
Cocaine | 31.9 | 34.8 | 0.52 |
Heroine | 16.6 | 5.6 | 0.001*, ** |
Cannabis | 6.6 | 8.1 | 0.54 |
Benzodiazepines | 7.2 | 5.2 | 0.11 |
Polysubstance users | 56.6 | 26.1 | 0.0001*, ** |
Prior detoxification admissions | 59.7 | 36.6 | 0.0001*, ** |
Binge consumption prior to admission | 53.3 | 53.3 | 0.99 |
Positive breath alcohol test | 23.8 | 28 | 0.32 |
Positive urinalysis | 61.3 | 55.3 | 0.08 |
Psychopharmacological and psychological treatment | |||
Antiepileptic | 71.3 | 82.2 | 0.45 |
Antidepressant | 59.3 | 76.3 | 0.38 |
Antipsychotic | 45.3 | 57.2 | 0.21 |
Benzodiazepines | 6.9 | 6.8 | 0.986 |
Opioid agonists | 9.3 | 16.3 | 0.08 |
Interdictors | 17.9 | 23.8 | 0.73 |
p < 0.05;
Statistically significant after Bonferroni correction.